Us Bancorp \De\ Ironwood Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 62,402 shares of IRWD stock, worth $220,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,402

Previous 62,349 0.09%

Holding current value

$220,279

Previous $406,000 36.95%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$3.93 - $7.04 $208 - $373	53 Added 0.09%	62,402 $256,000
Q2 2024 Aug 06, 2024	BUY	$5.58 - $8.61 $92,510 - $142,745	16,579 Added 36.22%	62,349 $406,000
Q1 2024 May 07, 2024	BUY	$8.32 - $15.45 $49,337 - $91,618	5,930 Added 14.88%	45,770 $398,000
Q4 2023 Feb 09, 2024	BUY	$8.79 - $11.51 $345,315 - $452,170	39,285 Added 7078.38%	39,840 $455,000
Q3 2023 Nov 03, 2023	SELL	$8.25 - $11.35 $13,455 - $18,511	-1,631 Reduced 74.61%	555 $5,000
Q2 2023 Aug 09, 2023	BUY	$10.1 - $11.6 $10,170 - $11,681	1,007 Added 85.41%	2,186 $23,000
Q1 2023 May 09, 2023	SELL	$10.37 - $12.56 $18,831 - $22,808	-1,816 Reduced 60.63%	1,179 $12,000
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $1,395 - $1,752	141 Added 4.94%	2,995 $37,000
Q3 2022 Oct 27, 2022	SELL	$10.14 - $12.38 $67,583 - $82,512	-6,665 Reduced 70.02%	2,854 $29,000
Q2 2022 Aug 01, 2022	SELL	$11.05 - $12.72 $44,653 - $51,401	-4,041 Reduced 29.8%	9,519 $110,000
Q1 2022 May 11, 2022	BUY	$10.61 - $12.88 $6,238 - $7,573	588 Added 4.53%	13,560 $171,000
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $14,595 - $18,748	1,344 Added 11.56%	12,972 $151,000
Q3 2021 Nov 10, 2021	SELL	$11.92 - $13.92 $47,477 - $55,443	-3,983 Reduced 25.51%	11,628 $152,000
Q2 2021 Aug 05, 2021	SELL	$10.16 - $13.11 $7,894 - $10,186	-777 Reduced 4.74%	15,611 $201,000
Q1 2021 Apr 28, 2021	BUY	$9.04 - $11.86 $56,328 - $73,899	6,231 Added 61.35%	16,388 $183,000
Q4 2020 Feb 04, 2021	SELL	$9.05 - $12.2 $17,611 - $23,741	-1,946 Reduced 16.08%	10,157 $116,000
Q3 2020 Nov 10, 2020	BUY	$8.99 - $10.74 $106,702 - $127,473	11,869 Added 5072.22%	12,103 $109,000
Q2 2020 Aug 07, 2020	BUY	$9.14 - $11.97 $2,138 - $2,800	234 New	234 $2,000
Q2 2019 Aug 13, 2019	SELL	$9.8 - $12.89 $1,215 - $1,598	-124 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$8.27 - $12.73 $1,025 - $1,578	124 New	124 $2,000
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $561 - $1,161	-72 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$11.13 - $13.63 $5,698 - $6,978	-512 Reduced 87.67%	72 $1,000
Q4 2017 Feb 02, 2018	BUY	$12.16 - $14.58 $5,350 - $6,415	440 Added 305.56%	584 $9,000
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $1,738 - $2,141	144	144 $2,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account